| Phase 4 |
| NCT07405086 |
Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or… |
Advanced Biliary Tract Carcinoma |
Recruiting |
| Phase 2 |
| NCT05705492 |
Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With… |
Advanced Malignant Solid Neoplasm |
Recruiting |
| NCT07228273 |
Induction and Consolidation With Fludarabine, Cytarabine, Idarubicin, and Venetoclax for… |
Acute Myeloid Leukemia |
Recruiting |
| NCT06895473 |
Intrathecal Cytarabine, Methotrexate, and Hydrocortisone for the Prevention of High-Grade… |
Hematopoietic and Lymphatic System Neoplasm |
Recruiting |
| NCT03270059 |
Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central… |
Central Nervous System Neoplasm |
Recruiting |
| NCT06504459 |
Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine… |
Acute Monocytic Leukemia |
Recruiting |
| NCT06067438 |
Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive… |
Atrial Fibrillation |
Recruiting |
| NCT04529044 |
177Lu-DOTATATE for the Treatment of Stage IV or Recurrent Breast Cancer |
Anatomic Stage IV Breast Cancer AJCC v8 |
Recruiting |
| NCT04539808 |
NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery… |
Pancreatic Adenocarcinoma |
Active, Not Recruiting |
| NCT04267887 |
Advanced ChemoHormonal Therapy for Treatment Naive Metastatic Prostate Cancer |
Castration-Sensitive Prostate Carcinoma |
Active, Not Recruiting |
| NCT07434128 |
Mammogram Pretreatment With Ulipristal Acetate |
Mammography Screening |
Not Yet Recruiting |
| NCT06157099 |
Atorvastatin for Preventing Disease Metastasis in Patients With Resected High-Risk Stage… |
Pathologic Stage IIIA Cutaneous Melanoma AJCC v8 |
Active, Not Recruiting |
| NCT07498517 |
Safety and Efficacy of a Single Dose of Gruticibart to Prevent CRT |
Thrombosis |
Not Yet Recruiting |
| NCT07511504 |
Y-90 Radioembolization, Durvalumab, Tremelimumab, and Zanzalintinib for the Treatment of… |
Locally Advanced Hepatocellular Carcinoma |
Not Yet Recruiting |
| NCT02312557 |
Pembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer… |
Castration-Resistant Prostate Carcinoma |
Active, Not Recruiting |
| Phase 1/2 |
| NCT06320405 |
Axatilimab in Combination With Retifanlimab and Paclitaxel for the Treatment of Patients… |
Advanced Malignant Solid Neoplasm |
Recruiting |
| NCT06357676 |
Glofitamab Plus Ibrutinib With Obinutuzumab for the Treatment of Patients With Mantle… |
Mantle Cell Lymphoma |
Recruiting |
| NCT06249191 |
Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc… |
Diffuse Large B-Cell Lymphoma |
Recruiting |
| NCT02522715 |
Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Castration-Resistant… |
Castration-Resistant Prostate Carcinoma |
Active, Not Recruiting |
| Phase 1 |
| NCT03361436 |
Eribulin and Radiation Therapy in Treating Patients With Retroperitoneal Liposarcoma That… |
Liposarcoma |
Active, Not Recruiting |
| NCT04104139 |
TAS-102 With Concurrent Radiation for the Treatment of Untreated Resectable Stage II-III… |
Rectal Adenocarcinoma |
Active, Not Recruiting |
| NCT07548983 |
Ruxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid… |
Acute Myeloid Leukemia |
Not Yet Recruiting |
| NCT05396859 |
Entrectinib in Combination With ASTX727 for the Treatment of Relapsed/Refractory TP53… |
Acute Myeloid Leukemia |
Active, Not Recruiting |
| NCT04872790 |
Venetoclax, Dasatinib, Prednisone, Rituximab and Blinatumomab for the Treatment of Newly… |
B Acute Lymphoblastic Leukemia |
Active, Not Recruiting |
| Early Phase 1 |
| NCT04005690 |
Targeted Pathway Inhibition in Patients With Pancreatic Cancer |
Locally Advanced Pancreatic Ductal Adenocarcinoma |
Recruiting |